MedPath

Evaluating effect of remifentanil in post-operative hyperalgesia and prophylactic effect of magnesium sulfate on it

Phase 2
Conditions
Hypotension due to drugs.
I95.2
Hypotension due to drugs
Nitroglycerin and other nitric acids and esters
T65
Registration Number
IRCT2014071216415N3
Lead Sponsor
Deputy of Research and technology of Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
105
Inclusion Criteria

Age 15 to 65 years old; ASA 1 and 2; without history of usage of neuro-psychological drugs; without history of usage of NSAIDs; no contraindication for TNG; no contraindication for magnesium sulfate; no contraindication for remifentanil

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of pain. Timepoint: Before discharge from recovery; 6 hours after surgery; 24 hours after surgery. Method of measurement: By VAS.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath